Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $56 price target.
Needham Reiterates Buy on Genpact, Maintains $56 Price Target
Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $56 price target.
Related Posts
Novo Nordisk’s Weight Loss Drugs Like Wegovy, Ozempic May Pose Serious Stomach Risks, Study Suggests
A recent study published in JAMA has raised concerns about the potential risks associated with popular weight loss and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO), Wegovy (semaglutide), Ozempic (semaglutide), and Saxenda (liraglutide).
What’s Going On With AT&T Stock Today? Analyst Cites Lead-Sheathed Cables As ‘Uncertain Risks’
AT&T Inc (NYSE: T) shares are trading lower Tuesday after Jim Cramer discouraged investors from investing in the telecommunications giant
Singapore Airlines Offers Up To $25,000 In Compensation To Passengers After Fatal Turbulence Incident
Singapore Airlines has offered compensation to passengers of a flight that encountered extreme turbulence last month, resulting in one fatality and multiple injuries.